The medical world is witnessing a remarkable shift in glucose treatment with the emergence of GLP-1 transdermal devices. These systems offer a potentially more comfortable alternative to shots of GLP-1 medications, minimizing the need for daily needle pricks. The technology releases the medication directly through the epidermis, potentially enhanci